New Cardiovascular Horizons. Baton Rouge. State of the Art Cardiology and Advanced Limb Preservation Techniques. Louisiana January 24, 2015

Transcription

1 New Cardiovascular Horizons Baton Rouge State of the Art Cardiology and Advanced Limb Preservation Techniques Louisiana January 24, 2015 Chairmen: Deepak Thekkott, MD Craig M. Walker, MD

2

3 TABLE OF CONTENTS Accreditation... Agenda... Faculty... Notes

4 ACCREDITATION This activity is jointly provided by Continuing Medical Education Resources and New Cardiovascular Horizons Foundation. TARGET AUDIENCE Family Physicians, General Practice Physicians, Primary Care Providers, Internists, Cardiologists, Interventional Cardiologists, Vascular Medicine Specialists, Podiatrists, Cath Lab Technologists, Residents/Fellows, Physician Assistants, Advanced Practice Nurses, Nurses, Allied Health Professionals and Healthcare Administrators. STATEMENT OF NEED/PROGRAM OVERVIEW State of the Art Cardiology and Advanced Limb Preservation Techniques will focus on new developments, treatments, and technology available for Coronary Artery Disease, Valvular Heart Disease, Atrial Fibrillation, Hypertension, Cardiovascular Imaging, Lipidology, Peripheral Artery Disease, and Venous Disease. EDUCATIONAL HIGHLIGHTS Upon completion of this program, participants should be able to: Evaluate new imaging and testing available for CAD. Review and evaluate interventional devices and appropriate uses. Review new trends in less invasive surgery. Discuss the current state of healthcare in the US: Where we are and where we are going? Assess the role of the physician in management of PAD: From screening to limb salvage. PHYSICIAN ACCREDITATION STATEMENT This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through a joint sponsorship with the New Cardiovascular Horizons Foundation. Continuing Medical Education Resources is accredited by the ACCME to provide continuing medical education for physicians. Continuing Medical Education Resources designates this live educational activity for a maximum of 7.75 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity. NURSING CONTINUING EDUCATION This activity has been planned and implemented in accordance with the Essential Areas and Policies of the American Nurses Credentialing Center (ANCC) through a joint sponsorship with the New Cardiovascular Horizons Foundation CNE contact hours will be granted for the successful completion (sign-in, full attendance and completion of program evaluation) of this activity. Our Lady of the Lake College is an approved provider of continuing nursing education by South Central Accreditation Program, an accredited approver by the American Nursing Credentialing Center s Commission on Accreditation. 2

5 ACCREDITATION AMERICAN SOCIETY OF RADIOLOGIC TECHNOLOGISTS This activity is approved for credit by the ASRT for 9.0 Category A Credits. FEE INFORMATION & REFUND/CANCELLATION POLICY There is a $25 Early Bird Registration, $50 Advance Registration or $100 On-Site Registration fee for this educational activity. Cancellations made in writing and/or postmarked by January 16, 2015 at 5:00 pm (CST) will receive a full refund. No refunds after January 16, 2015 at 5:00 pm (CST). No refunds for no shows. DISCLOSURE OF CONFLICTS OF INTEREST New Cardiovascular Horizons Foundation requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by New Cardiovascular Horizons for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Faculty Richard Abben, MD Venkat Banda, MD Charles Boudreaux, Jr., JD Walter Bringaze, MD Satish Gadi, MD Garland Green, MD Azeem Khan, MD David Konur, FACHE Robert Lawrence, RRT Vinod Nair, MD Randall Olson, MBA, FACHE Amit Patel, MD Louis Salvaggio, MD Glen Schwartzberg, MD Mrugesh Soni, MD Robert St. Amant, MD Parker Templeton, FACHE Deepak Thekkoott, MD Charles Thompson, MD Kalyan Veerina, MD Craig M. Walker, MD Disclosures at time of Printing at time of Printing at time of Printing Covidien-Honoraria-Teaching Avinger, Inc.-Honoraria-Teaching Honoraria-Speaking-Kowa, Amarin, CardioDx at time of Printing Forest Pharmacuticals-Honoraria-Speaking Spectranetics Corporation-Stocks, Stock Options, other Ownership Interest-Heartflow, Inc.-Stockholder Spectranetics Corporation-Honoraria-Teaching Spectranetics Corporation-Consulting Fee-Advisory Committee IDEV Technologies, Inc.-Stocks, Stock Options, other Ownership Interest-Stockholder IDEV Technologies, Inc.-Honoraria-Consulting-Other Medtronic, Inc.-Stocks, Stock Options, other Ownership Interest-Stockholder Cardiva Medical, Inc.-Stocks, Stock Options, other Ownership Interest-Stockholder Stocks, Stock Options, other Ownership Interest-Cardioprolific- Stockholder Stocks, Stock Options, other Ownership Interest-Vasamed-Other Abbott Laboratories-Honoraria- Speaking AstraZeneca-Honoraria-Speaking Bristol-Myers Squibb Sanofi Pharmaceuticals Partnership-Honoraria- Speaking Daiichi Sankyo-Honoraria-Speaking Boston Scientific Corporation-Honoraria-Teaching Boston Scientific Corporation-Consulting Fee-Advisory Committee 3

6 ACCREDITATION DISCLOSURE OF UNLABELED USE This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. New Cardiovascular Horizons Foundation does not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. DISCLAIMER Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer s product information, and comparison with recommendations of other authorities. CERTIFICATE INSTRUCTIONS If you have any questions regarding accreditation or certificates, please visit the registration table located in the foyer outside of the meeting room. Physical accreditation certificates will not be issued at this conference: they will be available 5 business days after the conference. Each attendee will receive a post meeting with instructions on obtaining your certificate. PHOTOGRAPHY Please be advised that photographs may be taken at the meeting for use On the conference website and on conference social media pages. In the press, including marketing materials and publications distributed to the public. By entering the meeting, you consent to the use of your image and likeness for the purposes mentioned above. 4

7

8 HIPG encourages the team approach to limb preservation and the use of interventional and surgical technologies to prevent amputation. Striving to reach our goals will increase the quality of life and improve outcomes for the patients and their families in which we are privileged to serve.

9 My Leg My Choice Foundation is a 501(c)(3) non-profit foundation committed to educating patients who are at risk for foot, leg or lower leg amputations due to diabetes and/or Peripheral Artery Disease (P.A.D.). We strive to bring awareness to patients, caregivers and communities about the warning signs of P.A.D., treatment options, and new technologies available if given the diagnosis or referral for amputation. Health experts have long recognized that undetected and untreated P.A.D. contributes to diminished quality of life, decreased functional status, and increased rates of lower extremity amputation, heart attack, stroke, and death. Visit us online for a list of upcoming events, screenings and support opportunities

10 AGENDA 7:30 AM Breakfast Symposium (Sponsored by AstraZeneca: NON-CME) Understanding High Triglycerides Peter Toth, MD, PhD The Session Current 1 State of Peripheral Artery Disease (PAD) 8:30 AM 8:45 AM 9:00 AM 9:15 AM 9:30 AM 9:45 AM 10:00 AM 10:15 AM 10:30 AM 10:40 AM 10:55 AM 11:10 AM 11:25 AM 8 Impact of PAD: Prevalence, Risk Factors, Testing, and Medical Management Garland Green, MD New Modalities and Advanced Techniques: The Role of Crossing Devices and Atherectomy Satish Gadi, MD Carotid Artery Disease: Current State of Interventional Treatment as an Option for High Risk Surgical Patients Deepak Thekkoott, MD A Surgeon s Perspective on PAD: New Surgical Techniques Glen Schwartzberg, MD Advanced Lipids and Current State of Management: New Guidelines from a Lipidologist Robert St. Amant, MD Role of Drug Eluting Stents, Drug Coated Balloons, and Limb Salvage Amit Patel, MD Current State of Cardiac Electrophysiology: New Techniques and Technologies Richard Abben, MD Current State of PAD from a World Leader, Visionary, and True Innovator: The Role of the Cardiologist in Management of PAD from Screenings to Limb Salvage Craig Walker, MD Questions and Answers/Panel Discussion Break/Exhibits The Current State of Health Care in the US: Where We Are and Where We Are Going Health Informatics: 2015 and Beyond Vinod Nair, MD Medical Update on Legal Issues for 2015: Where We Are and Where We Are Going Charles Boudreaux, Jr., JD Health Care Environment in 2015: From a Hospital CEO Perspective Randall Olson, MBA, FACHE

11 AGENDA 11:40 AM 11:55 AM 12:10 PM 12:25 PM 12:30 PM 1:45 PM 2:00 PM 2:15 PM 2:30 PM 2:45 PM 3:00 PM 3:15 PM 3:30 PM 3:45 PM 3:55 PM 4:10 PM The Role of Clinically Integrated Networks in Louisiana: 2015 and Beyond Parker Templeton, FACHE State of Health Care: A Cardiology Group Practice Perspective David Konur, FACHE Lean and Six Sigma: New Concept for All Healthcare Organizations Venkat Banda, MD Questions and Answers/Panel Discussion Lunch/Exhibits Coronary Artery Disease (CAD) Management Prevalence, Screening, Prevention Strategies, and Imaging Modalities for CAD Satish Gadi, MD Current State of Management for Acute Coronary Syndromes Mrugesh Soni, MD New Anti-Anginal Agents and Anti-Platelets Amit Patel, MD Radial Artery Interventions: From a Cath Lab Director Perspective Robert Lawrence, RRT Radial Artery Interventions: Acute Myocardial Infarction and Peripheral Artery Disease Deepak Thekkoott, MD Percutaneous Valve Replacement for Aortic Valve Disease: From a Cardiologist Perspective Louis Salvaggio, MD Current State of Surgical Management in CAD: New Surgical Techniques Walter Bringaze, MD Current State of Management for Pulmonary Hypertension Charles Thompson, MD Questions and Answers/Panel Discussion Break/Exhibits Coronary Artery Disease (CAD) Management Percutaneous AAA: Non-Surgical Management of Abdominal Aneurysm Kalyan Veerina, MD 9

12 AGENDA 4:25 PM 4:40 PM 4:55 PM 5:10 PM 5:25 PM 5:55 PM 6:00 pm 7:00 pm The Future of Robotic Bypass Azeem Khan, MD Atrial Fibrillation: Current State of Management with Importance to Newer Anticoagulation Medications and Devices Garland Green, MD Loop Recorders, Pacemakers, and Subcutaneous ICD: The Evolution of Technology in the EP World Charles Thompson, MD Synopsis of Management on Ventricular Arrhythmias Mrugesh Soni, MD Challenging and Most Exciting Cases in Cardiology: Don t Miss This Exciting Session Satish Gadi, MD Garland Green, MD Amit Patel, MD Mrugesh Soni, MD Deepak Thekkoott, MD Charles Thompson, MD Closing Remarks Deepak Thekkoott, MD Reception (Sponsored by ) 10

13 CHAIRMEN Deepak Thekkoott, MD Zachary, LA Craig M. Walker, MD Clinical Professor of Medicine Tulane University School of Medicine New Orleans, LA Clinical Professor of Medicine LSU School of Medicine New Orleans, LA Founder, President, and Medical Director Houma, LA FACULTY Richard Abben, MD Houma, LA David Konur, FACHE Houma, LA Robert St. Amant, MD Baton Rouge General Medical Center Baton Rouge, LA Venkat Banda, MD Baton Rouge General Medical Center Baton Rouge, LA Robert Lawrence, RRT Zachary, LA Mrugesh Soni, MD Zachary, LA Charles Boudreaux, Jr., JD Preis & Roy Lafayette, LA Vinod Nair, MD Houma, LA Parker Templeton, FACHE Iberia Medical Center New Iberia, LA Walter Bringaze, MD CVT Surgical Center Baton Rouge, LA Randy Olson, MBA, FACHE Lane Regional Medical Center Zachary, LA Charles Thompson, MD Zachary, LA Satish Gadi, MD Baton Rouge, LA Garland Green, MD Baton Rouge, LA Azeem Kahn, MD CVT Surgical Center Baton Rouge, LA Amit Patel, MD Baton Rouge, LA Louis Salvaggio, MD Lafayette, LA Glen Schwartzberg, MD Baton Rouge Clinic Baton Rouge, LA Kalyan Veerina, MD Opelousas, LA 11

14 NOTES 12

15

16